STEK | tickerfilter.com

Fundamental analysis

39%

Profitability 35%

Dept financing 43%

Liquidity 6%

Performance 50%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-33.33%

1 Month

-33.33%

3 Months

-77.78%

6 Months

-98.51%

1 Year

-99.43%

2 Year

-99.60%

Key data

Stock price

$0.00

P/E Ratio

0.00

DAY RANGE

$0.00 - $0.00

EPS

-$0.01

52 WEEK RANGE

$0.00 - $0.04

52 WEEK CHANGE

-$99.40

MARKET CAP

1.951 M

YIELD

N/A

SHARES OUTSTANDING

231.975 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$143,605,534

AVERAGE 30 VOLUME

$62,488,046

Company detail

CEO:
Region: US
Website: stemtech.com
Employees: 0
IPO year: 2022

Issue type:
Market: OTCM
Industry: Wholesale/Wholesale – Drugs & Drug Proprietaries
Sector: Wholesale Trade

Stemtech Corporation develops and sells various dietary supplements. It offers stemrelease3, a stem cell enhancer, which supports the body's natural renewal system, a general sense of wellbeing, and telomeres health, as well as promotes youthful and healthy aging. MigraStem, a natural source of potent antioxidants, phytonutrients, fiber, and polysaccharides, optimizes the migration of stem cells, enhance the immune system performance, support detoxification and anti-oxidative functions.

STEK - Stemtech Corp